Familial Cancer

, Volume 9, Issue 3, pp 431–438 | Cite as

Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma

  • M. H. Abdel-Rahman
  • R. Pilarski
  • S. Ezzat
  • J. Sexton
  • F. H. Davidorf
Article

Abstract

Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. The extent of the contribution of familial/hereditary predisposition to the development of uveal melanoma is largely unknown. Thus we sought to ascertain the frequency of cancers in patients with UM and their family members to identify the prevalence of hereditary/familial predisposition to cancer in these patients. An unselected series of 121 patients with UM seen in a university-based tertiary referral program were consented to the study. Cancer histories (site and age of diagnosis) were obtained for all first- and second-degree relatives. Patients/families were classified as being potentially at high risk for hereditary predisposition if they met any of the following criteria: (1) Diagnosis of UM at age 30 or under, (2) Two or more cases of UM in the family, (3) UM plus at least one other primary cancer in the same patient (excluding non-melanoma skin and cervix cancers due to their strong environmental etiological link). (4) Family history meeting high risk criteria for a known hereditary cancer predisposition syndrome as defined by Hampel et al. (J Med Genet 41(2): 81–91, 2004). One patient had a family history of UM (0.8%). Ten patients (8.3%) had a personal and/or family history consistent with predisposition to a known hereditary cancer syndrome including six with possible hereditary breast, two with hereditary colon and two with hereditary melanomas. Twenty three patients (19%) had a personal history of a second cancer after exclusion of non-melanoma skin and cervical cancers. The frequency of cutaneous melanomas was significantly higher in UM patients than the general population (RR: 2.97, 95% CI: 1.00–6.94). Patients with a family history suggestive of a high risk predisposition to a known cancer syndrome had a significantly higher risk for having a second cancer than the remaining UM patients (P = 0.02). Our results indicate that the frequency of UM patients with high risk for a hereditary cancer predisposition is much higher than earlier estimates (0.6%) and that it could be as high as 11.6%. Our results suggest that cancer phenotypes in these patients are diverse and include cancers other than UM. Thus, alerting ophthalmologists to the need for expanding their cancer family history intake to include other cancers is warranted. It also suggests that patients with a hereditary predisposition to UM have a higher risk for the development of other cancers and that characterization of the germline genetic alterations in these patients is highly warranted.

Keywords

Uveal melanoma Eye neoplasm Familial cancer Hereditary cancer  Predisposition 

Notes

Acknowledgments

This work is funded by the Patti Blow Research fund in Ophthalmology and a Selective Investment grant from the College of Medicine, the Ohio State University. The authors would like to thank Dr. Judith Westman and Ms. Heather Hampel for their critical revision of the manuscript and helpful comments.

Supplementary material

10689_2010_9328_MOESM1_ESM.doc (32 kb)
Supplementary material 1 (DOC 32 kb)

References

  1. 1.
    Hampel H, Sweet K, Westman JA, Offit K, Eng C (2004) Referral for cancer genetics consultation: a review, compilation of risk assessment criteria. J Med Genet 41(2):81–91CrossRefPubMedGoogle Scholar
  2. 2.
    Singh AD, Damato B, Howard P, Harbour JW (2005) Uveal melanoma: genetic aspects. Ophthalmol Clin North Am 18(1): 85–97, viiiGoogle Scholar
  3. 3.
    Singh AD, Rennie IG, Seregard S, Giblin M, McKenzie J (2004) Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol 49(4):419–428CrossRefPubMedGoogle Scholar
  4. 4.
    Barker-Griffith AE, Streeten BW (2004) Familial uveal melanoma: a report of four cases in two families and literature review. Can J Ophthalmol 39(4):403–408PubMedGoogle Scholar
  5. 5.
    Kodjikian L, Nguyen K, Lumbroso L et al (2003) Familial uveal melanoma: a report on two families and a review of the literature. Acta Ophthalmol Scand 81(4):389–395CrossRefPubMedGoogle Scholar
  6. 6.
    Hearle N, Damato BE, Humphreys J et al (2003) Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma. Invest Ophthalmol Vis Sci 44(2):458–462CrossRefPubMedGoogle Scholar
  7. 7.
    Scott RJ, Vajdic CM, Armstrong BK et al (2002) BRCA2 mutations in a population-based series of patients with ocular melanoma. Int J Cancer 102(2):188–191CrossRefPubMedGoogle Scholar
  8. 8.
    Iscovich J, Abdulrazik M, Cour C, Fischbein A, Pe’er J, Goldgar DE (2002) Prevalence of the BRCA2 6174 del T mutation in Israeli uveal melanoma patients. Int J Cancer 98(1):42–44CrossRefPubMedGoogle Scholar
  9. 9.
    Sinilnikova OM, Egan KM, Quinn JL et al (1999) Germline brca2 sequence variants in patients with ocular melanoma. Int J Cancer 82(3):325–328CrossRefPubMedGoogle Scholar
  10. 10.
    Jonsson G, Bendahl PO, Sandberg T et al (2005) Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32. J Natl Cancer Inst 97(18):1377–1382CrossRefPubMedGoogle Scholar
  11. 11.
    Singh AD, Shields CL, De Potter P et al (1996) Familial uveal melanoma. Clinical observations on 56 patients. Arch Ophthalmol 114(4):392–399PubMedGoogle Scholar
  12. 12.
    Wooster R, Bignell G, Lancaster J et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789–792CrossRefPubMedGoogle Scholar
  13. 13.
    Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66–71CrossRefPubMedGoogle Scholar
  14. 14.
    Lynch HT, Smyrk TC, Watson P et al (1993) Genetics, natural history, tumor spectrum, pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104(5):1535–1549PubMedGoogle Scholar
  15. 15.
    Canning CR, Hungerford J (1988) Familial uveal melanoma. Br J Ophthalmol 72(4):241–243CrossRefPubMedGoogle Scholar
  16. 16.
    Hemminki K, Jiang Y (2001) Association of ocular melanoma with breast cancer but not with cutaneous melanoma: results from the Swedish Family-Cancer Database. Int J Cancer 94(6):907–909CrossRefPubMedGoogle Scholar
  17. 17.
    Diener-West M, Reynolds SM, Agugliaro DJ et al (2005) Second primary cancers after enrollment in the COMS trials for treatment of choroidal melanoma: COMS Report No. 25. Arch Ophthalmol 123(5):601–604CrossRefPubMedGoogle Scholar
  18. 18.
    Bergman L, Nilsson B, Ragnarsson-Olding B, Seregard S (2006) Uveal melanoma: a study on incidence of additional cancers in the Swedish population. Invest Ophthalmol Vis Sci 47(1):72–77CrossRefPubMedGoogle Scholar
  19. 19.
    Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E (1997) Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89(3):227–238CrossRefPubMedGoogle Scholar
  20. 20.
    Couch FJ, DeShano ML, Blackwood MA et al (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336(20):1409–1415CrossRefPubMedGoogle Scholar
  21. 21.
    Shattuck-Eidens D, Oliphant A, McClure M et al (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA 278(15):1242–1250CrossRefPubMedGoogle Scholar
  22. 22.
    Chen S, Wang W, Lee S et al (2006) Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296(12):1479–1487CrossRefPubMedGoogle Scholar
  23. 23.
    Wijnen JT, Vasen HF, Khan PM et al (1998) Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 339(8):511–518CrossRefPubMedGoogle Scholar
  24. 24.
    Breslow NE, Day NE (1987) Statistical methods in cancer research. In: Breslow NE, Day NE (eds) The design and analysis of cohort studies. International Agency for Research on Cancer, LyonGoogle Scholar
  25. 25.
    Taeger D, Sun Y, Keil U, Straif K (2000) A stand-alone windows applications for computing exact person-years, standardized mortality ratios, confidence intervals in epidemiological studies. Epidemiology 11(5):607–608CrossRefPubMedGoogle Scholar
  26. 26.
    Soufir N, Bressac-de Paillerets B, Desjardins L et al (2000) Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes. Br J Cancer 82(4):818–822CrossRefPubMedGoogle Scholar
  27. 27.
    Lynch HT, Brand RE, Hogg D et al (2002) Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer 94(1):84–96CrossRefPubMedGoogle Scholar
  28. 28.
    Hemminki K, Chen B (2006) Familial risks for eye melanoma and retinoblastoma: results from the Swedish Family-Cancer Database. Melanoma Res 16(2):191–195CrossRefPubMedGoogle Scholar
  29. 29.
    Davidorf FH, Abdel-Rahman MH, Craven M-A, Ohr M, Jarjoura D (2007) Higher colon cancer risk in uveal melanoma patients and their relatives compared to general population. Invest Ophthalmol Vis Sci 48(5):4790Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • M. H. Abdel-Rahman
    • 1
    • 2
    • 5
  • R. Pilarski
    • 2
  • S. Ezzat
    • 3
    • 4
  • J. Sexton
    • 1
  • F. H. Davidorf
    • 1
  1. 1.Department of OphthalmologyThe Ohio State UniversityColumbusUSA
  2. 2.Clinical Cancer Genetics Program, Department of Internal Medicine and Comprehensive Cancer CenterThe Ohio State UniversityColumbusUSA
  3. 3.Department of Public HealthMenoufiya UniversityShebin El-KomEgypt
  4. 4.Department of BiostatisticsChildren Cancer HospitalCairoEgypt
  5. 5.ColumbusUSA

Personalised recommendations